Genscript Biotech Corp

Genscript Biotech's GHG Emissions Data Preview

In 2024, Genscript Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).

However, Genscript Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)	2024	2023	2022	2021 - 2017
Total Scope 1 Total direct GHG emissions from categories that are owned or directly controlled by the company.	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Scope 2 Indirect GHG emissions from the generation of purchased electricity, steam, heating, and cooling consumed by the reporting company.
Market-Based Indirect emissions from purchased energy calculated using the market-based method, which reflects contractual instruments such as supplier-specific emission factors or renewable energy certificates (RECs).	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Location-Based Indirect emissions from purchased energy calculated using the location-based method, which reflects average emission factors of the local grid.	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Scope 3 All other indirect GHG emissions that occur in the company’s value chain, outside of Scope 1 and 2. This includes both upstream and downstream activities.	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Genscript Biotech's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Genscript Biotech amounted to 151,664.17 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Genscript Biotech increased by 14.39%, suggesting that the company faced challenges in reducing its emissions from its core operations.

Insights into Genscript Biotech's Value Chain Emissions

In 2024, Genscript Biotech reported 387,028 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.

The 2024 disclosure of Genscript Biotech includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.

Insights into Genscript Biotech's Total Carbon Footprint

In 2024, Genscript Biotech reported a total carbon footprint of 538,692.17 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 20.45% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.

The largest contributor to Genscript Biotech's total carbon footprint was Scope 3 emissions, accounting for 71.85% of the company's total carbon footprint, followed by Scope 2 emissions at 20.84%.